Wells Fargo Downgrades MEI Pharma To Market Perform

Analysts at Wells Fargo downgraded

from Outperform to Market Perform. MEI Pharma shares have dropped 80.10% over the past 52 weeks, while the S&P 500 index has surged 12.80% in the same period. MEI Pharma's shares rose 4.66% to $2.02 in pre-market trading.